Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2025-12-25 @ 9:09 PM
Study NCT ID:
NCT00417456
Status:
COMPLETED
Last Update Posted:
2012-03-16
First Post:
2006-12-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
The Development and Evaluation of an "E-Visit" Program for the Management of Acne
Sponsor:
Massachusetts General Hospital
Organization:
Study Overview
Official Title:
The Development and Evaluation of an "E-Visit" Program for the Management of Acne
Status:
COMPLETED
Status Verified Date:
2012-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to test the efficacy, timeliness, and user satisfaction of an online "E-Visit" application that uses store-and-forward technology for acne patients requiring dermatologic care for their condition. Hypotheses:
1. That an "E-Visit" is an effective alternative to in-person clinic care for patients with mild to severe facial acne.
2. That providers and patients will be satisfied with this model.
3. That mean wait times for new and return visits will be reduced through the "E-Visit" model.
4. That this prototype for care will improve clinic workflow, offer additional patient access, and allow urgent cases to be seen earlier.
1. That an "E-Visit" is an effective alternative to in-person clinic care for patients with mild to severe facial acne.
2. That providers and patients will be satisfied with this model.
3. That mean wait times for new and return visits will be reduced through the "E-Visit" model.
4. That this prototype for care will improve clinic workflow, offer additional patient access, and allow urgent cases to be seen earlier.
Detailed Description:
Across the United States, a geographically mal-distributed workforce of Dermatologists exists, a problem that is projected to worsen. Patient access to dermatologic care is threatened. The dermatology workforce shortage has resulted in long wait times for patients, especially new patient visits and acute care cases.
Teledermatology has received much attention as a solution to the preceding problems. Teledermatology can reduce the burden of repeat office visits in chronic conditions by facilitating care from home. In this trial, a model incorporating store-and-forward technology is tested in general clinics while its impact on clinical outcomes, satisfaction, and wait times are studied.
Comparison: After consent, study subjects are assigned a unique study number and randomly assigned to one of two groups:
Group 1- The first group of subjects will have four (4) in-office visits spaced six weeks apart.
Group 2- The second group will have four (4) "e-visits" spaced six weeks apart.
At the end of study (after completion of 5th visit overall) all participants will complete a satisfaction survey.
Teledermatology has received much attention as a solution to the preceding problems. Teledermatology can reduce the burden of repeat office visits in chronic conditions by facilitating care from home. In this trial, a model incorporating store-and-forward technology is tested in general clinics while its impact on clinical outcomes, satisfaction, and wait times are studied.
Comparison: After consent, study subjects are assigned a unique study number and randomly assigned to one of two groups:
Group 1- The first group of subjects will have four (4) in-office visits spaced six weeks apart.
Group 2- The second group will have four (4) "e-visits" spaced six weeks apart.
At the end of study (after completion of 5th visit overall) all participants will complete a satisfaction survey.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: